Literature DB >> 6502180

Remission in spasmodic torticollis.

D Jayne, A J Lees, G M Stern.   

Abstract

In 26 patients with spasmodic torticollis followed up for a median period of 12 years, the frequency of sustained remission was 23%, the median duration of remission was 8 years and duration of torticollis before remission 3 years. These results are more favourable than stated in the literature and should be taken into consideration before recommending surgical treatment.

Entities:  

Mesh:

Year:  1984        PMID: 6502180      PMCID: PMC1028093          DOI: 10.1136/jnnp.47.11.1236

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  5 in total

1.  Natural history of spasmodic torticollis, and effect of surgery.

Authors:  R Meares
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

2.  Familial spasmodic torticollis.

Authors:  G J Gilbert
Journal:  Neurology       Date:  1977-01       Impact factor: 9.910

3.  Features which distinguish groups of spasmodic torticollis.

Authors:  R Meares
Journal:  J Psychosom Res       Date:  1971-03       Impact factor: 3.006

4.  Spasmodic torticollis: a combined clinical study.

Authors:  W B Matthews; P Beasley; W Parry-Jones; G Garland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-06       Impact factor: 10.154

5.  Alpha methylparatyrosine and tetrabenazine in movement disorders.

Authors:  A E Lang; C D Marsden
Journal:  Clin Neuropharmacol       Date:  1982-12       Impact factor: 1.592

  5 in total
  3 in total

Review 1.  The genetics of primary torsion dystonia.

Authors:  U Müller; K G Kupke
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

2.  Spasmodic torticollis: the problem of pathophysiology and assessment.

Authors:  J J van Hoof; M W Horstink; H J Berger; K P van Spaendonck; A R Cools
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

Review 3.  Psychogenic movement disorders: diagnosis and management.

Authors:  Madhavi Thomas; Joseph Jankovic
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.